Indivior Pharmaceuticals Inc
INDV
Hisse Senetlerindeki Sıralama
#4015
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Hisse Fiyatı
$32.56
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$4.06B
Değişim (1 gün)
-3.15%
Değişim (1 yıl)
33.01%
Ülke
US
Ticaret Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
Indivior Pharmaceuticals Inc (INDV) için EPS
June 2026 itibariyle EPS TTM: $2.84
Indivior Pharmaceuticals Inc şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $2.84'dir. 2023 yılı sonunda, şirketin EPS'si $0.01 idi; bu, 2022 yılındaki EPS olan $-0.37 ile önceki yıla göre artış.
Indivior Pharmaceuticals Inc için 2016 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
